Manufacturer record
IOSIS Remedies Pvt Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
7 batches manufactured by IOSIS Remedies Pvt Ltd (Himachal Pradesh) were declared Not of Standard Quality between May 2019 and March 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
7 records linked to IOSIS Remedies Pvt Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Prochlorperazine Maleate Mouth Dissolving Tablets | NMD5T-020Mfg 2025-04 · Exp 2027-03 | Disintegration & AssayAssay | DTL, ThrissurState lab | Mar 2026 |
| Ambroxol, Terbutaline, Guaiphenesin & Menthol Syrup | BRAS-065Mfg 2025-05 · Exp 2027-10 | ContentOther | Drugs Testing Laboratory, Madurai-19State lab | Jan 2026 |
| Amlodipine Besylate and Atenolol Tablets(Amlobact AT ) | ABAT-035Mfg 2024-11 · Exp 2027-04 | ContentOther | Drugs Testing Laboratory, Madurai-19State lab | Dec 2025 |
| Lelet-M Syrup (Montelukast Sodium and levocetirizine hydrochloride syrup) | LLMS-063Mfg 2024-04 · Exp 2026-03 | sample does not conform to label claim with respect to content of Montelukast in Montelukast sodiumLabelling | DTL MaduraiState lab | Apr 2025 |
| PANTOPRAZOLE (EC) & DOMPERIDONE (SR) CAPSULES IP (PANTIAC-DSR) | PTRC-149Mfg 2023-02 · Exp 2025-01 | THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR PANTOPRAZOLE AND DOMPERIDONE CAPSULES FOR THE DISSOLUTION TEST (PANTOPRAZOLE) .Dissolution | State Lab MaharashtraState lab | Jun 2024 |
| Telmisartan Tablets I.P. (Telmimac 40 mg Tablets) | TC4T-027Mfg 2020-05 · Exp 2022-10 | DissolutionDissolution | RDTL ChandigarhState lab | Nov 2020 |
| Clopican* A (Clopidogrel Bisulphate and Aspirin Tablets) | CCAT-018Mfg 2018-10 · Exp 2020-09 | Free Salicylic Acid TestOther | CDL KolkataCDSCO lab | May 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.